|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 University of Texas Southwestern Med Cntr, Dallas, Texas, United States
2 Indiana University School of Medicine, Indianapolis, Indiana, United States
3 University of Texas Southwestern Medical Center, Dallas, Texas, United States
4 University of Texas Southwestern Med Cntr, Dallas, Texas, United States; University of Texas, Southwestern Med Cntr, Dallas, Texas, United States
* To whom correspondence should be addressed. E-mail: steven.kliewer{at}utsouthwestern.edu.
The heart adapts to changes in nutritional status and energy demands by adjusting its relative metabolism of carbohydrates and fatty acids. Loss of this metabolic flexibility such as occurs in diabetes mellitus is associated with cardiovascular disease and heart failure. To study the long-term consequences of impaired metabolic flexibility, we have generated mice that overexpress pyruvate dehydrogenase kinase 4 (PDK4) selectively in heart. Hearts from PDK4 transgenic mice have a marked decrease in glucose oxidation and a corresponding increase in fatty acid catabolism. Although no overt cardiomyopathy was observed in the PDK4 transgenic mice, introduction of the PDK4 transgene into mice expressing a constitutively active form of the phosphatase calcineurin, which causes cardiac hypertrophy, caused cardiomyocyte fibrosis and a striking increase in mortality. These results demonstrate that cardiac-specific overexpression of PDK4 is sufficient to cause a loss of metabolic flexibility that exacerbates cardiomyopathy caused by the calcineurin stress-activated pathway.
This article has been cited by other articles:
![]() |
L. Hue and H. Taegtmeyer The Randle cycle revisited: a new head for an old hat Am J Physiol Endocrinol Metab, September 1, 2009; 297(3): E578 - E591. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Palomer, D. Alvarez-Guardia, R. Rodriguez-Calvo, T. Coll, J. C. Laguna, M. M. Davidson, T. O. Chan, A. M. Feldman, and M. Vazquez-Carrera TNF-{alpha} reduces PGC-1{alpha} expression through NF-{kappa}B and p38 MAPK leading to increased glucose oxidation in a human cardiac cell model Cardiovasc Res, March 1, 2009; 81(4): 703 - 712. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sidhu, A. Gangasani, L. G. Korotchkina, G. Suzuki, J. A. Fallavollita, J. M. Canty Jr., and M. S. Patel Tissue-specific pyruvate dehydrogenase complex deficiency causes cardiac hypertrophy and sudden death of weaned male mice Am J Physiol Heart Circ Physiol, September 1, 2008; 295(3): H946 - H952. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Sugden PDC deletion: the way to a man's heart disease Am J Physiol Heart Circ Physiol, September 1, 2008; 295(3): H917 - H919. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |